Latest Asset Sales News

360 Capital REIT has completed a $10 million structured equity investment in a new Sydney apartment project, boosting its FY26 earnings forecast by 10% without raising capital.

Newmont Corporation reported a strong third quarter in 2025, driven by higher gold prices and successful divestitures of non-core assets, enhancing liquidity and reducing debt. The company’s operational shifts and cost management reflect a strategic pivot in a volatile market.

Abbott has received Overseas Investment Office approval to acquire Synlait Milk’s North Island manufacturing and warehouse facilities in a US$178 million deal, pending shareholder consent.

Tigers Realm Coal's planned sale of its Russian subsidiaries faces ongoing delays due to regulatory hurdles and buyer demands for further price cuts, leaving the transaction in limbo and the company suspended from ASX trading.

Alcoa Corporation reported a $232 million net income in Q3 2025 despite significant restructuring costs, driven by increased alumina and aluminum production and strategic asset sales.

Heartland Group Holdings reported a solid first quarter for FY2026, with improved profitability, stable costs, and accelerated realisation of non-strategic assets surpassing expectations.

Aeris Resources reported solid Q1 FY26 results with steady copper and gold production, disciplined cost management, and advancing divestment plans for non-core assets.

Jupiter Energy reported steady oil sales of US$1.65 million in Q3 2025, all through domestic channels, while nearing completion of a key gas pipeline integration that promises operational efficiencies.

National Storage REIT delivered robust FY25 results, surpassing earnings guidance and expanding its development pipeline, while advancing sustainability and technology initiatives.

TZ Limited has turned down a non-binding offer from Quadient SA for its US Smart Locker subsidiary, Telezygology Inc., citing undervaluation and strategic importance of its Data Centre Security division. The company is now initiating a strategic review to explore future options for the business.

Eden Innovations is set to complete the sale of its Georgia industrial property for US$5 million, aiming to significantly reduce its debt burden. The sale proceeds will primarily repay over US$4 million of the company’s iBorrow loan, easing financing costs.

Vectus Biosystems has agreed to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics for US$3 million in shares and warrants, gaining a strategic equity position while refocusing on its cardiovascular and fibrosis pipeline.